# FDA Inspection 1008933 - Jeffrey S. Overcash, MD - February 03, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/jeffrey-s-overcash-md/db67b284-691b-4e7e-a6f1-caccd45c26c7
Source feed: FDA_Inspections

> FDA Inspection 1008933 for Jeffrey S. Overcash, MD on February 03, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008933
- Company Name: Jeffrey S. Overcash, MD
- Inspection Date: 2017-02-03
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1223615 - 2023-11-17](https://www.globalkeysolutions.net/records/fda_inspections/jeffrey-s-overcash-md/a86f2307-c632-447c-8001-4e41c129a7d9)
- [FDA Inspection 1072272 - 2018-11-09](https://www.globalkeysolutions.net/records/fda_inspections/jeffrey-s-overcash-md/6ef23d9f-a395-4186-ad53-3a249c56d029)
- [FDA Inspection 874640 - 2014-04-14](https://www.globalkeysolutions.net/records/fda_inspections/jeffrey-s-overcash-md/37d9015b-e084-4088-86fd-ae0d84532dea)

Company: https://www.globalkeysolutions.net/companies/jeffrey-s-overcash-md/ac67a2af-442c-4f20-9b04-471344dadf99

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c